TP53 and neoplasm: Virotherapy is a tumor-specific strategy, in which viruses engineered to selectively kill tumor cells, through targeted alterations in the cancer such as p53 mutation, viral deletion, tissue-specific transcriptional control or tumor-specific receptors, thus, representing a promising approach for the treatment of neoplastic diseases refractory to conventional therapies (1,2).